(1S,3R)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester | 303984-26-1

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: (1S,3R)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester
• 英文别名: (1S,3R)-trans-methyl 1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate；methyl (1S,3R)-1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
• CAS: 303984-26-1
• 化学式: C₂₀H₂₀N₂O₃
• 分子量: 336.39
• InChiKey: YCCPHMBIMIJBPW-MSOLQXFVSA-N

物化性质

• 熔点：
  219-222 °C(Solv: dichloromethane (75-09-2); ethyl acetate (141-78-6))
• 沸点：
  520.2±50.0 °C(Predicted)
• 密度：
  1.243±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  63.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1S,3R)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester 在 trialkylamine 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 6.0h， 生成 (6S,12aR)-2-(2-(1-benzylpiperidin-4-yl)ethyl)-6-(4-methoxyphenyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione
  参考文献：
  名称：

  Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5)

  摘要：

  On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compound 2 has proven this method was feasible in AD mouse models. In this study, our work focused on exploring alternative novel tadalafil derivatives (3a-s). Among the 19 analogues, compound 3c exhibited good selective dual-target AChE/PDE5 inhibition and good blood-brain barrier (BBB) permeability. Moreover, its citrate (3c center dot Cit) possessed improved water solubility and good effects against scopolamine-induced cognitive impairment with inhibition of cortical AChE activities and enhancement of cAMP response element-binding protein (CREB) phosphorylation ex vivo.

  DOI：

  10.1021/acschemneuro.8b00014
• 作为产物：
  描述：

  methyl (1S,3R)-1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride 在 potassium carbonate 作用下， 以 水 、 乙酸乙酯 为溶剂， 生成 (1S,3R)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester
  参考文献：
  名称：

  Syntheses of chiral 1,3-disubstituted tetrahydro-β-carbolines via CIAT process: highly stereoselective Pictet–Spengler reaction of d-tryptophan ester hydrochlorides with various aldehydes

  摘要：

  A highly stereoselective Pictet-Spengler reaction of D-tryptophan methyl ester hydrochloride 1-HCl with various aldehydes via a CIAT (crystallization-induced asymmetric transformation) process is described. It was revealed that the CIAT process should be performed in a mixed solvent of nitromethane and toluene, and a fine tuning of the ratio of nitromethane and toluene for each epimer Mixture of 2-HCl was necessary in order to get as high yields and stereoselectivities as possible. Enantiomerically pure cis (or trans) 1,3-disubstituted tetrahydro-beta-carbolines 2a-2v were obtained by recrystallization or flash chromatography after neutralization of the corresponding hydrochloride salts cis-2-HCl or trans-2-HCl. (c) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2009.01.026

文献信息

• Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-β-carbolines as a new class of antimalarial agents
  作者：Leena Gupta、Kumkum Srivastava、Shubhra Singh、S.K. Puri、Prem M.S. Chauhan

  DOI：10.1016/j.bmcl.2008.04.030

  日期：2008.6

  A series of hybrid molecules 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines have been synthesized and screened for their in vitro antimalarial activity against chloroquine-sensitive strains of Plasmodium falciparum. Compounds 26, 32, and 34 have shown MIC in the range of 0.05-0.11 microM and are in vitro several folds more active than chloroquine

  合成了一系列杂化分子2- [3-（7-氯喹啉-4-基氨基）-烷基] -1-（取代的苯基）-2,3,4,9-四氢-1H-β-咔啉并筛选了它们对恶性疟原虫氯喹敏感菌株的体外抗疟活性。化合物26、32和34的MIC在0.05-0.11 microM的范围内，并且在体外具有比氯喹高几倍的活性。
• Pictet-spengler cyclization in room temperature ionic liquid: A convenient access to tetrahydro β-carbolines
  作者：M. Muthukrishnan、Shivaji V. More、Dinesh R. Garud、C. V. Ramana、R. R. Joshi、R. A. Joshi

  DOI：10.1002/jhet.5570430337

  日期：2006.5

  1,2,3,4-Tetrahydro-β-carbolines have been synthesized in moderate to good yields in short reaction time using the ionic liquid [bbim] BF4 as reaction medium and promoter. There was no need for the use of an additional catalyst normally employed in Pictet-Spengler condensation.

  使用离子液体[bbim] BF 4作为反应介质和促进剂，已在较短的反应时间内以中等至良好的产率合成了1,2,3,4-四氢-β-咔啉。无需使用通常在Pictet-Spengler缩合反应中使用的其他催化剂。
• Tetrahydro-β-carboline derivatives as potent histone deacetylase 6 inhibitors with broad-spectrum antiproliferative activity
  作者：Xin Chen、Jiayun Wang、Peng Zhao、Baiyun Dang、Ting Liang、Raphael R. Steimbach、Aubry K. Miller、Jia Liu、Xin Wang、Tongtong Zhang、Xiaofa Luan、Jiadong Hu、Jinming Gao

  DOI：10.1016/j.ejmech.2023.115776

  日期：2023.11

  application of scaffold hopping strategy. Several THβC analogues were highly potent (IC50 < 5 nM) and selective against HDAC6 enzyme and exhibited good antiproliferative activity against human multiple myeloma (MM) cell. Molecular docking interpreted the structure activity relationship (SAR). Target engagement of HDAC6 was confirmed in RPMI-8226 cells using the WB assay. In vitro, (1S, 3R)-1-(4-chloro

  应用支架跳跃策略合理设计并合成了一系列基于四氢β-咔啉（TH β C）的异羟肟酸作为新型选择性HDAC6抑制剂（sHDAC6is）。几种 TH β C 类似物对 HDAC6 酶具有高效能（IC 50 < 5 nM）和选择性，并对人多发性骨髓瘤(MM) 细胞表现出良好的抗增殖活性。分子对接解释了结构活性关系（SAR）。使用 WB 测定在 RPMI-8226 细胞中证实了 HDAC6 的靶标参与。体外，(1 S , 3 R )-1-(4-氯苯基) -N -(4-(羟基氨基甲酰基)苄基)-2,3,4,9-四氢-1H-吡啶并[3, 4- b ] indole-3-carboxamide ( 14g ) 对各种肿瘤（包括白血病、结肠癌、黑色素瘤和乳腺癌细胞系）表现出有效、广泛的抗增殖活性，优于 ACY-1215。此外， 14g在小鼠口服给药中也表现出良好的药代动力学特性。
• Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis <i>In Vivo</i>
  作者：John T. Randolph、Matthew J. O’Connor、Fei Han、Charles W. Hutchins、Y. Amy Siu、Min Cho、Yunan Zheng、Jonathan A. Hickson、Jana L. Markley、Vlasios Manaves、Mikkel Algire、Kenton A. Baker、Alex M. Chapman、Sujatha M. Gopalakrishnan、Sanjay C. Panchal、Kelly Foster-Duke、DeAnne F. Stolarik、Anita Kempf-Grote、Darby Dammeier、Stacey Fossey、Qi Sun、Chaohong Sun、Yu Shen、Michael J. Dart、Warren M. Kati、Albert Lai、Ari J. Firestone、Michael E. Kort

  DOI：10.1021/acs.jmedchem.2c01415

  日期：2023.3.23

  Compounds that inhibit glutathione peroxidase 4 (GPX4) hold promise as cancer therapeutics in their ability to induce a form of nonapoptotic cell death called ferroptosis. Our research identified 24, a structural analog of the potent GPX4 inhibitor RSL3, that has much better plasma stability (t1/2 > 5 h in mouse plasma). The bioavailability of 24 provided efficacious plasma drug concentrations with

  抑制谷胱甘肽过氧化物酶 4 (GPX4) 的化合物有望作为癌症治疗药物，因为它们能够诱导一种称为铁死亡的非凋亡性细胞死亡。我们的研究发现24是强效 GPX4 抑制剂 RSL3 的结构类似物，具有更好的血浆稳定性（小鼠血浆中的t 1/2 > 5 h）。24的生物利用度为 IP 给药提供了有效的血浆药物浓度，从而使体内研究能够评估耐受性和疗效。使用 GPX4 敏感肿瘤模型对小鼠进行的一项功效研究发现，剂量为24高达 50 mg/kg 的剂量可耐受 20 天，但对肿瘤生长没有影响，尽管在肿瘤匀浆中观察到部分靶点参与。
• (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy
  申请人：ICOS Corporation

  公开号：EP2036560A1

  公开（公告）日：2009-03-18

  Compound (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino [2', 1':6,1]pyrido[3,4-b]indcle-1,4-dione for the treatment of benign prostatic hypertrophy.

  用于治疗良性前列腺肥大的化合物 (6R,12aR)-2,3,6,7,12,12a-六氢-2-甲基-6-(3,4-亚甲基二氧苯基)-吡嗪并[2', 1':6,1]pyrido[3,4-b]indcle-1,4- 二酮。